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In terms of pathogenic mechanisms, the prion paradigm unifies a number of age-related, 51 incurable neurodegenerative disorders that are caused by protein misfolding and aggregation 52 [13, 21, 22, 9] . These disorders include human and animal forms of prion diseases, Alzheimer's 53 disease, Parkinson's disease and Huntington's disease. In principle, host-encoded monomeric 54 proteins or peptides are converted into misfolded and aggregated assemblies, which serve as 55 seeds or templates for further autocatalytic conversion. In prion diseases, the ubiquitously 56 expressed, host-encoded prion protein PrP C is converted into a misfolded, -sheet-rich 57 conformer termed PrP Sc [39] . In susceptible host species and in laboratory rodent models, PrP 47, 48, 5] . The strain-specific 60 structural differences can be observed at the secondary structural level in terms of local 61 structural variation but also at the quaternary level with strain-specific size distributions 62 [44, 49, 47] . A large body of evidence supports the view for further structural diversity within 63 specific prion populations and strains: i) some studies highlight the selection of prion substrains 64 during the transmission of natural isolates [11, 27, 2] While the kinetic aspects of prion replication 'as a whole' have been comprehensively described 73 by measuring infectivity or PrP Sc levels in the brain (see references [25, 34] as examples), the 74 7 fraction 15 (peak P2). The relative proportions of P1 and P2 varied among the three strains; P2 131 was barely detected in the 139A amplicons. These data indicate that during mb-PMCA 132 amplification, two populations of PrP Sc assemblies are generated that differ according to their 133 quaternary structures, with a predominance of small assemblies. 134
The bimodal (i.e., generation of two peaks) and discrete behavior of the size distribution as well 135 as the formation of predominantly small assemblies in P1 suggest that the mb-PMCA 136 condition(s) can be a consequence of shearing forces during the sonication step [1, 38, 51] rather 137 than an intrinsic consequence of the replication process. To discriminate between these two 138 possibilities, undiluted 127S seeds (i.e., 20% brain homogenate) were incubated and sonicated 139 in identical mb-PMCA conditions but without the PrP C substrate (i.e., in PrP 0/0 brain lysate). 140
As shown in Figure 1E , the size distribution analysis of these sonicated 127S seeds in the PrP 0/0 141 substrate revealed mostly the presence of larger-sized assemblies, as observed upon 142 solubilization at 37°C [24] , thus ruling out the mb-PMCA conditions being at the origin of the 143 formation of small-size assemblies. 144
Altogether, these observations suggest that in vivo, the early phase of replication for the 127S, 145 139A and vCJD prion strains generates mainly small-sized assemblies. Similar to in vivo 146 replication, the mb-PMCA amplification condition generates two sets of PrP assemblies that 147 differ in their quaternary structures. The formation of these two groups of assemblies is 148 common to the three strains used here. 149 150 P1 and P2 contain two structurally distinct PrP res assemblies 151 We next asked whether the formation of P2 resulted from a simple condensation of assemblies 152 present in the P1 peak (Oswald ripening process [53]) or from an alternative templating 153 pathway. To address this question, we first examined the influence of the amplification rate on 154 8 the formation of these two species by varying the concentration of the seed used as the template 155 for the mb-PMCA reaction. We compared the SV-sedimentograms of the mb-PMCA products 156 seeded with 10 -3 to 10 -10 diluted 127S brain homogenate. As shown in Figure 2A , as a function 157 of the seed concentration, the relative amounts of assemblies in P1 decreased as the amounts of 158 those from P2 increased. The variation in the P1 and P2 peak surface area as a function of the 159 logarithm of the dilution factor revealed a quasi-linear decrease in P1 when the P2 peak surface 160 followed a sigmoidal increase ( Figure 2B ). The sigmoidal increase in P2 to the detriment of the 161 quasi-linear decrease in P1 surface indicates that i) the formation of PrP res assemblies present in 162 P2 follows a seed concentration-dependent cooperative process and that ii) the formation of the 163 P2 peak does not result from the simple condensation of assemblies present in P1 as the 164 variations in P1 and P2 are uncorrelated ( Figure 2B ). This observation strongly suggests that 165 assemblies forming the P1 and P2 peaks result from distinct polymerization pathways and should 166 therefore be structurally distinct. 167
To further explore the entanglement between the assemblies forming P1 and P2, we fixed the 168 mb-PMCA regime to favor the formation of the P1 peak by fixing high dilutions of the inoculum 169 seed, followed by quiescent incubations at 37°C for variable periods. As shown with the 127S 170 prions, the SV analysis at defined incubation time points post-PMCA reaction revealed a 171 decrease in the population of P1 in favor of P2 ( Figure 2C ). At 4 h postincubation, there were 172 equal proportions of assemblies forming P1 and P2. At 24 h, most of the PrP res assemblies were 173 located in the P2 peak. Comparing the distribution in isopycnic gradients [24] of the PrP res 174 populations at 0h and 24h of quiescent incubation at 37°C revealed a quasi-similar density for 175 PrP res assemblies composing the P1 and the P2 peaks ( Figure 2D ). This observation leads us to 176 conclude that i) the low sedimentation velocity of the assemblies forming P1 does not result 177 from an interaction with lipids or other low-density molecules and ii) the sedimentation velocity9 increase of P2 compared to P1 results strictly from a quaternary structure rearrangement through 179 size increase rather than change in compactness reducing the hydrodynamic radius. 180
As shown in Figure 2E , the formation of assemblies sedimenting in P2 exhibited bimodal 181 behavior (i.e., absence of assemblies of intermediate size) without any significant shift in the 182 P2 peak position, suggesting that the formation of these assemblies resulted from the association 183 with a specific number of assemblies present in P1. Furthermore, the time-dependent surface 184 variation in P1 and P2 showed a sigmoidal shape, indicating that the assemblies present in P2 185 enhance their own formation according to an autocatalytic process ( Figure 2E) . Similarly, the 186 139A and vCJD prions showed a bimodal evolution of P1 to P2 during a 24-h quiescent phase 187 ( Figure 2F ), arguing in favor of a generic process of transformation. 188
To determine whether the quaternary structure rearrangement accompanying the transformation 189 of P1 to P2 was in concert with a deeper structural rearrangement in the PrP Sc assemblies, we 190 determined the specific infectivity of the P1 and P2 assemblies. A 127S-PMCA product was 191 fractionated at the end of the reaction or after 48 h of quiescent incubation. Pools of fractions 192 corresponding to the P1 and P2 peaks were inoculated into reporter tg338 mice. The specific 193 infectivity (infectivity per PrP molecule), which is mostly associated to PrP res assemblies 194 [24, 49] , was calculated from the mean survival time using 127S dose-response curves [49] . As 195 shown in Figure 2G , the specific infectivity of the P1 peak assemblies was 50-100-fold higher 196 than that of the P2 peak assemblies. This value did not change over a longer period of quiescent 197 incubation (7 days, Figure 2G Thus, at any moment of the process of assembly transformation of Ai to Bi, the following 247 equilibrium should be respected: 248
(1) 249 
Altogether, these six elementary steps constitute the reaction mechanism that describes the 267 transformation of Ai into Bi subassembly species. 268
To validate the designed mechanism, we translated these elementary reactions into time- Considering that the PrP Sc assemblies that constitute each strain are structurally distinct, one 326 can ask how distinct PrP Sc assemblies can all generate Ai assemblies that harbor strain structural 327 information while showing the same quaternary structure (at the SV resolution). The first 328 explanation can be the existence of a common narrow subpopulation of PrP Sc (with respect to 329 their quaternary structure) within the three strains that serves as the best replicator and 330 participates in the formation of Ai assemblies. However, the PrP Sc quaternary structure subset 331 that exhibits the highest specific infectivity in vivo (i.e., the best replicator) can be associated 332 16 with either small-size assemblies (i.e., 127S and 139A [24, 49] and Supplemental Figure 1A , 333 respectively) or high-molecular-weight assemblies (i.e., vCJD, Supplemental Figure 1B ) and is 334 therefore strain-dependent. The existence of a structurally common PrP Sc subpopulation is thus 335 unlikely to be at the origin of the generic formation of a small-size subset in the brain or Ai 336 assemblies in the mb-PMCA condition. Intrinsically, the early steps of the replication process 337 favor the emergence of mainly one subspecies Ai with a highly narrowed size distribution, 338 arguing in favor of a quaternary structural convergence phenomenon during these steps. This 339 structural convergence concerns the PrP domain that governs polymerization (the size of 340 assemblies). However, as the A assemblies harbor the strain structural determinant, one can 341 conclude that Ai assemblies present a certain degree of structural variability, allowing the 342 encoding of strain structural information (Supplemental Figure 1) . 343
All along the quiescent phase and for the three prion strains studied, the Ai assemblies constitute 344 the precursor species in the formation of Bi assemblies. Furthermore, the presence of PrP is generated ( Figure 5 ). The existence of a secondary autocatalytic process can be crucially 360 important for maintaining PrP Sc structural diversity throughout the evolution of the pathology. 361
In the absence of this secondary autocatalytic process, e.g., in the absence of PrP C , the system 362 selects the best replicator and the most thermodynamically stable assemblies. In the presence 363 of PrP C , the system escapes this rule, allowing the specific accumulation of the autocatalytic 364 product (here, the Bi assemblies) rather than the assemblies that are the most 365 thermodynamically stable or have highly specific infectivity. This phenomenon can explain 366 why, for certain prion strains, the most infectious assemblies represent a minor population, 367 while those with the lowest specific infectivity mostly accumulate [24, 49] . Figure 5 
